| Treatment Outcomes in Patients With Newly Diagnosed Epilepsy Treated With Established and New Antiepileptic Drugs: A 30-Year Longitudinal Cohort Study | JAMA Neurology | 2018 | 483 |
| SOAPnuke: a MapReduce acceleration-supported software for integrated quality control and preprocessing of high-throughput sequencing data | GigaScience | 2018 | 473 |
| A randomized, placebo-controlled trial of cenicriviroc for treatment of nonalcoholic steatohepatitis with fibrosis | Hepatology | 2018 | 376 |
| Cardiovascular outcomes with glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a meta-analysis | Lancet Diabetes and Endocrinology,the | 2018 | 336 |
| Tokyo Guidelines 2018: diagnostic criteria and severity grading of acute cholecystitis (with videos) | Journal of Hepato-Biliary-Pancreatic Sciences | 2018 | 324 |
| International Clinical Practice Guidelines for Sarcopenia (ICFSR): Screening, Diagnosis and Management | Journal of Nutrition, Health and Aging | 2018 | 276 |
| Renal tubule injury: a driving force toward chronic kidney disease | Kidney International | 2018 | 263 |
| Improvement in Overall Survival in a Randomized Study That Compared Dacomitinib With Gefitinib in Patients With Advanced Non-Small-Cell Lung Cancer and EGFR-Activating Mutations | Journal of Clinical Oncology | 2018 | 263 |
| The Gut Microbiota in the Pathogenesis and Therapeutics of Inflammatory Bowel Disease | Frontiers in Microbiology | 2018 | 258 |
| Middle East respiratory syndrome coronavirus: risk factors and determinants of primary, household, and nosocomial transmission | Lancet Infectious Diseases, The | 2018 | 251 |
| Mucosal microbiome dysbiosis in gastric carcinogenesis | Gut | 2018 | 249 |
| Asia-Pacific Working Party on Non-alcoholic Fatty Liver Disease guidelines 2017-Part 1: Definition, risk factors and assessment | Journal of Gastroenterology and Hepatology (Australia) | 2018 | 211 |
| Noninvasive biomarkers in NAFLD and NASH - current progress and future promise | Nature Reviews Gastroenterology and Hepatology | 2018 | 206 |
| Adherent-invasive in inflammatory bowel disease | Gut | 2018 | 204 |
| Final Overall Survival Analysis From a Study Comparing First-Line Crizotinib Versus Chemotherapy in ALK-Mutation-Positive Non-Small-Cell Lung Cancer | Journal of Clinical Oncology | 2018 | 197 |
| Vascular cognitive impairment | Nature Reviews Disease Primers | 2018 | 195 |
| Liver Ultrasound Elastography: An Update to the World Federation for Ultrasound in Medicine and Biology Guidelines and Recommendations | Ultrasound in Medicine and Biology | 2018 | 195 |
| Tokyo Guidelines 2018: diagnostic criteria and severity grading of acute cholangitis (with videos) | Journal of Hepato-Biliary-Pancreatic Sciences | 2018 | 191 |
| Risankizumab, an IL-23 inhibitor, for ankylosing spondylitis: results of a randomised, double-blind, placebo-controlled, proof-of-concept, dose-finding phase 2 study | Annals of the Rheumatic Diseases | 2018 | 188 |
| Antitumor Activity of Nivolumab in Recurrent and Metastatic Nasopharyngeal Carcinoma: An International, Multicenter Study of the Mayo Clinic Phase 2 Consortium (NCI-9742) | Journal of Clinical Oncology | 2018 | 185 |
| Bacteriophage transfer during faecal microbiota transplantation in infection is associated with treatment outcome | Gut | 2018 | 171 |
| Recent Advances in the Treatment of Breast Cancer | Frontiers in Oncology | 2018 | 165 |
| Multi-cohort analysis of colorectal cancer metagenome identified altered bacteria across populations and universal bacterial markers | Microbiome | 2018 | 165 |
| Epidemiology of diabetes and diabetic complications in China | Diabetologia | 2018 | 159 |
| Meta-analysis on shift work and risks of specific obesity types | Obesity Reviews | 2018 | 146 |
